GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice
Objective: Analogues of GDF15 (Growth Differentiation Factor 15) are promising new anti-obesity therapies as pharmacological treatment with GDF15 results in dramatic reductions of food intake and body weight. GDF15 exerts its central anorexic effects by binding to the GFRAL receptor exclusively expr...
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
Elsevier
2019-03-01
|
| シリーズ: | Molecular Metabolism |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2212877818311438 |